Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.

@article{Sung1997EchocardiographicEO,
  title={Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline.},
  author={Rita Y T Sung and Gary Y Huang and Ming Kong Shing and Stephen J. Oppenheimer and Chung Ki Li and Joseph Lau and M P Yuen},
  journal={International journal of cardiology},
  year={1997},
  volume={60 3},
  pages={239-48}
}
Using Doppler echocardiography, we studied the left ventricular systolic and diastolic function in 124 healthy control children (group C), 110 oncology patients who had received anthracycline (group A), and 76 oncology patients who had received chemotherapy not including anthracycline (group N), at rest and after supine bicycle exercise. The mean dosage of anthracycline that group A patients received was 219 +/- 95 mg/m2. Impaired systolic function was detected in 29% of the patients in group A… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Dexrazoxane does not protect against doxorubicin-induced damage in young rats.

American journal of physiology. Heart and circulatory physiology • 2003
View 1 Excerpt

Similar Papers

Loading similar papers…